Beyond Medical Announces Director Change
Rhea-AI Summary
Beyond Medical Technologies (CSE: DOCT, FSE: 7FM, OTC Pink: DOCKF) has announced a change in its board of directors. Hongming Luo has been appointed as a new director, bringing expertise in AI, Blockchain, Healthcare Tech, and derivatives markets. This appointment follows the resignation of Harveer Sidhu, effective February 4, 2025.
Positive
- Appointment of new director with expertise in AI, Blockchain, and Healthcare Tech sectors
Negative
- None.
News Market Reaction – DOCKF
On the day this news was published, DOCKF gained 55.56%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Vancouver, British Columbia--(Newsfile Corp. - February 5, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce that it has appointed Hongming Luo as a director of the Company. Mr. Luo brings extensive experience in the technology sector, namely focusing on AI, Blockchain and Healthcare Tech, as well as the derivatives markets. Mr. Luo replaces Harveer Sidhu, who has resigned as a director, effective February 4, 2025. The Company would like to thank Mr. Sidhu for his service and wishes him the best in his future endeavors.
On behalf of the Board of Directors
"Daniel Liu" Chief Executive Officer
Email: daniel@republictechs.com
https://beyond-md.ca/
Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/239697